Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
Clinical trial NCT04006288 · COMPLETED
Trial details
- NCT number
- NCT04006288
- Sponsor
- University of Florida
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-06
- Primary completion
- 2022-01-31
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.